|
Benefits of intensive multiple risk factor intervention
|
|
|
Potential benefits of multifactorial approaches
|
|
|
MRFIT: CVD mortality by diabetes status
|
|
|
Evidence base for multiple risk factor intervention
|
|
|
STENO-2 study: Clinical outcomes
|
|
|
STENO-2 study: Residual CV risk
|
|
|
Risk factors for coronary artery disease
|
|
|
Summary
|
|
|
Approaches to CVD prevention in diabetes
|
|
|
The prevention of CV complications
|
|
|
Frequently used therapies in diabetes
|
|
|
Key findings from recent lipid-lowering trials
|
|
|
Statins reduce all-cause death
|
|
|
Benefits of aggressive LDL-C lowering in diabetes
|
|
|
CARDS: cumulative hazard for any CVD endpoint
|
|
|
Key findings from recent BP-lowering trials
|
|
|
Syst-Eur study
|
|
|
Risk reductions from intervention studies in type 2 diabetes
|
|
|
Targets for glycaemic control
|
|
|
Risk reduction in UKPDS 75
|
|
|
UKPDS 34: Intensive glucose control and CV protection
|
|
Share this page with your colleagues and friends: